{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T17:35:10Z","timestamp":1783359310697,"version":"3.54.6"},"reference-count":31,"publisher":"Danish Medical Association","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ugeskr L\u00e6ger"],"abstract":"<jats:p>Psychiatric disease and its medical treatment can cause challenges regarding road safety. Several studies explored the subject, but the evidence is inconsistent. In this review, a systematic literature search was conducted to assess psychotropics and their driving impairment. The available evidence suggests that antidepressants with affinity for the H1-receptor, benzodiazepines, and first-generation antipsychotics impair driving ability. Patients possibly benefit from treatment with antidepressants concerning driving skills. However, due to inconsistent designs, more studies are needed.<\/jats:p>","DOI":"10.61409\/v07240479","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T10:46:28Z","timestamp":1755254788000},"page":"1-9","source":"Crossref","is-referenced-by-count":1,"title":["The impact of psychotropic drugs on driving performance"],"prefix":"10.61409","author":[{"given":"Michelle Illum","family":"Heesche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poul","family":"Videbech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"40208","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Kessing LV, Ziersen SC, Caspi A et al. Lifetime incidence of treated mental health disorders and psychotropic drug prescriptions and associated socioeconomic functioning. JAMA Psychiatry. 2023;80(10):1000-1008. https:\/\/doi.org\/10.1001\/jamapsychiatry.2023.2206","DOI":"10.1001\/jamapsychiatry.2023.2206"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Ravera S, van Rein N, de Gier JJ, de Jong-van den Berg LTW. Road traffic accidents and psychotropic medication use in the Netherlands: a case-control study. Br J Clin Pharmacol. 2011;72(3):505-13. https:\/\/doi.org\/10.1111\/j.1365-2125.2011.03994.x","DOI":"10.1111\/j.1365-2125.2011.03994.x"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Chang CM, Wu ECH, Chen CY et al. Psychotropic drugs and risk of motor vehicle accidents: a population-based case-control study. Br J Clin Pharmacol. 2012;75(4):1125-33. https:\/\/doi.org\/10.1111\/j.1365-2125.2012.04410.x","DOI":"10.1111\/j.1365-2125.2012.04410.x"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Olesen AV, Madsen TKO, Lahrmann H, Nielsen J. Use of psychotropic medication and risk of road traffic crashes: a registry-based case-control study in Denmark, 1996-2018. Psychopharmacology (Berl). 2022;239(8):2537-2546. https:\/\/doi.org\/10.1007\/s00213-022-06146-0","DOI":"10.1007\/s00213-022-06146-0"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Yang BR, Kwon KE, Kim YJ et al. The association between antidepressant use and deaths from road traffic accidents: a case-crossover study. Soc Psychiatry Psychiatr Epidemiol. 2019;54(4):485-495. Epub 2018 Nov 24. https:\/\/doi.org\/10.1007\/s00127-018-1637-4","DOI":"10.1007\/s00127-018-1637-4"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Rapoport MJ, Zagorski B, Seitz D et al. At-fault motor vehicle crash risk in elderly patients treated with antidepressants. Am J Geriatr Psychiatry. 2011;19(12):998-1006. https:\/\/doi.org\/10.1097\/JGP.0b013e31820d93f9","DOI":"10.1097\/JGP.0b013e31820d93f9"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Wingen M, Ramaekers JG, Schmitt JAJ. Driving impairment in depressed patients receiving long-term antidepressant treatment. Psychopharmacology (Berl). 2006;188(1):84-91. https:\/\/doi.org\/10.1007\/s00213-006-0471-7","DOI":"10.1007\/s00213-006-0471-7"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Robbe HW, O'Hanlon JF. Acute and subchronic effects of paroxetine 20 and 40 mg on actual driving, psychomotor performance and subjective assessments in healthy volunteers. Eur Neuropsychopharmacol. 1994;5(1):35-42. https:\/\/doi.org\/10.1016\/0924-977X(94)00130-4","DOI":"10.1016\/0924-977X(94)00130-4"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Iwamoto K, Takahashi M, Nakamura Y et al. The effects of acute treatment with paroxetine, amitriptyline, and placebo on driving performance and cognitive function in healthy Japanese subjects: a double-blinded crossover trial. Hum Psychopharmacol. 2008;23(5):399-407. https:\/\/doi.org\/10.1002\/hup.939","DOI":"10.1002\/hup.939"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Wingen M, Bothmer J, Langer S, Ramaekers JG. Actual driving performance and psychomotor function in healthy subjects after acute and subchronic treatment with escitalopram, mirtazapine, and placebo: a crossover trial. J Clin Psychiatry. 2005;66(4):436-43. https:\/\/doi.org\/10.4088\/JCP.v66n0405","DOI":"10.4088\/JCP.v66n0405"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"O'Hanlon JF, Robbe HWJ, Vermeeren A et al. Venlafaxine's effects on healthy volunteers' driving, psychomotor, and vigilance performance during 15-day fixed and incremental dosing regimens. J Clin Psychopharmacol. 1998;18(3):212-21. https:\/\/doi.org\/10.1097\/00004714-199806000-00006","DOI":"10.1097\/00004714-199806000-00006"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Theunissen EL, Street D, H\u00f8jer AM et al. A randomized trial on the acute and steady-state effects of a new antidepressant, vortioxetine (Lu AA21004), on actual driving and cognition. Clin Pharmacol Ther. 2013;93(6):493-501. https:\/\/doi.org\/10.1038\/clpt.2013.39","DOI":"10.1038\/clpt.2013.39"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Van der Sluiszen NNJJM, Vermeeren A, van Dijken JH et al. Driving performance and neurocognitive skills of long-term users of sedating antidepressants. Hum Psychopharmacol. 2020;36(1):1-12. Epub 2020 Oct 1. https:\/\/doi.org\/10.1002\/hup.2762","DOI":"10.1002\/hup.2762"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Iwamoto K, Kawano N, Kohmura K et al. Effects of low-dose mirtazapine on driving performance in healthy volunteers. Hum Psychopharmacol. 2013;28(5):523-8. https:\/\/doi.org\/10.1002\/hup.2327","DOI":"10.1002\/hup.2327"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Miyata A, Iwamoto K, Kawano N et al. Driving performance of stable outpatients with depression undergoing real-world treatment. Psychiatry Clin Neurosci. 2018;72(6):399-408. https:\/\/doi.org\/10.1111\/pcn.12648","DOI":"10.1111\/pcn.12648"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Rapoport MJ, Lanct\u00f4t KL, Streiner DL et al. Benzodiazepine use and driving: a meta-analysis. J Clin Psychiatry. 2009;70(5):663-73. https:\/\/doi.org\/10.4088\/JCP.08m04325","DOI":"10.4088\/JCP.08m04325"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Van der Sluiszen NNJJM, Vermeeren A, Verster JC et al. Driving performance and neurocognitive skills of long-term users of benzodiazepine anxiolytics and hypnotics. Hum Psychopharmacol. 2019;34(6):e2715. https:\/\/doi.org\/10.1002\/hup.2715","DOI":"10.1002\/hup.2715"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Osler M, J\u00f8rgensen MB. Association of benzodiazepines, Z-drugs, pregabalin, and melatonin with traffic accidents: a nationwide cohort and case-crossover study in Danish adults. J Psychopharmacol. 2022;36(4):470-478. https:\/\/doi.org\/10.1177\/02698811221080465","DOI":"10.1177\/02698811221080465"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Dubois S, Bedard M, Weaver B. The impact of benzodiazepines on safe driving. Traffic Inj Prev. 2008;9(5):404-13. https:\/\/doi.org\/10.1080\/15389580802161943","DOI":"10.1080\/15389580802161943"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"De Gier JJ, 't Hart BJ, Nelemans FA, Bergman H. Psychomotor performance and real driving performance of outpatients receiving diazepam. Psychopharmacology (Berl). 1981;73(4):340-344. https:\/\/doi.org\/10.1007\/BF00426462","DOI":"10.1007\/BF00426462"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Jongen S, Vuurman EFPM, Ramaekers JG, Vermeeren A. Comparing the effects of oxazepam and diazepam in actual highway driving and neurocognitive test performance: a validation study. Psychopharmacology (Berl). 2018;235(4):1283-1294. https:\/\/doi.org\/10.1007\/s00213-018-4844-5","DOI":"10.1007\/s00213-018-4844-5"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Leufkens TRM, Vermeeren A, Smink BE, van Ruitenbeek P. Cognitive, psychomotor and actual driving performance in healthy volunteers after immediate and extended release formulations of alprazolam 1 mg. Psychopharmacology (Berl). 2007;191(4):951-9. https:\/\/doi.org\/10.1007\/s00213-006-0669-8","DOI":"10.1007\/s00213-006-0669-8"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Verster JC, Volkerts ER, Verbaten MN. Effects of alprazolam on driving ability, memory functioning and psychomotor performance: a randomized, placebo-controlled study. Neuropsychopharmacology. 2002;27(2):260-9. https:\/\/doi.org\/10.1016\/S0893-133X(02)00310-X","DOI":"10.1016\/S0893-133X(02)00310-X"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Stone BT, Correa KA, Brown TL et al. Behavioral and neurophysiological signatures of benzodiazepine-related driving impairments. Front Psychol. 2015;6:1799. https:\/\/doi.org\/10.3389\/fpsyg.2015.01799","DOI":"10.3389\/fpsyg.2015.01799"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Daurat A, Sagaspe P, Mot\u00e1k L et al. Lorazepam impairs highway driving performance more than heavy alcohol consumption. Accid Anal Prev. 2013;60:31-4. https:\/\/doi.org\/10.1016\/j.aap.2013.08.004","DOI":"10.1016\/j.aap.2013.08.004"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Hindmarch I, Gudgeon A. The effects of clobazam and lorazepam on aspects of psychomotor performance and car handling ability. Br J Clin Pharmacol. 1980;10(2):145-50. https:\/\/doi.org\/10.1111\/j.1365-2125.1980.tb01731.x","DOI":"10.1111\/j.1365-2125.1980.tb01731.x"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Laurell H, T\u00f6rnros J. The carry\u2010over effects of triazolam compared with nitrazepam and placebo in acute emergency driving situations and in monotonous simulated driving. Acta Pharmacol Toxicol (Copenh). 1986;58(3):182-6. https:\/\/doi.org\/10.1111\/j.1600-0773.1986.tb00092.x","DOI":"10.1111\/j.1600-0773.1986.tb00092.x"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Brunnauer A, Laux G, Zwick S. Driving simulator performance and psychomotor functions of schizophrenic patients treated with antipsychotics. Eur Arch Psychiatry Clin Neurosci. 2009;259(8):483-9. https:\/\/doi.org\/10.1007\/s00406-009-0014-4","DOI":"10.1007\/s00406-009-0014-4"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Babulal GM, Chen L, Trani JF et al. Major depressive disorder and driving behavior among older adults. JAMA Netw Open. 2024;7(12):e2452038. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.52038","DOI":"10.1001\/jamanetworkopen.2024.52038"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Shen J, Moller HJ, Wang X et al. Mirtazapine, a sedating antidepressant, and improved driving safety in patients with major depressive disorder: a prospective, randomized trial of 28 patients. J Clin Psychiatry. 2009;70(3):370-7. https:\/\/doi.org\/10.4088\/JCP.08m04234","DOI":"10.4088\/JCP.08m04234"},{"key":"ref30","unstructured":"Forfattere kan kontaktes for fuldst\u00e6ndig referenceliste."}],"container-title":["Ugeskrift for L\u00e6ger"],"original-title":[],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T13:19:55Z","timestamp":1758892795000},"score":1,"resource":{"primary":{"URL":"https:\/\/ugeskriftet.dk\/videnskab\/V07240479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":31,"URL":"https:\/\/doi.org\/10.61409\/v07240479","relation":{},"ISSN":["0041-5782","1603-6824"],"issn-type":[{"value":"0041-5782","type":"print"},{"value":"1603-6824","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]}}}